Dihydrochalcone
Based on 1 Customer Validation
Dihydrochalcone (3-Phenylpropiophenone) is a Aβ aggregation inhibitor. Dihydrochalcone destabilizes Aβ17-42 protofibrils by disrupting the β-sheet of β1 region. Dihydrochalcone destabilizes both U-shaped Aβ40/Aβ42 protofibrils and S-shaped Aβ42 protofibrils by binding to the protofibril cavity. Dihydrochalcone is the main component of daemonorops draco tree.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.87%
- CAS No.: 1083-30-3
- Formule: C15H14O
- Masse moléculaire:210.27
-
Stockage:
Store at room temperature 3 years.
In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
Lipid Compound Library
HY-L043
-
Anti-Alzheimer's Disease Compound Library
HY-L069
-
Neurodegenerative Disease-related Compound Library
HY-L086
-
Human Metabolite Library
HY-L123
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
High-Throughput Bioactive Compound Library
HY-L205
-
Drug Fragment Library
HY-L904
-
Neuronal Signaling Compound Library
HY-L013
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CM-AS16 | IC50 |
>100 μM
Compound: D1
|
Antiproliferative activity against human CM-AS16 cells cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay
Antiproliferative activity against human CM-AS16 cells cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay
|
[PMID: 36868105] |
| CRMM-1 | IC50 |
>100 μM
Compound: D1
|
Antiproliferative activity against human CRMM-1 cells cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay
Antiproliferative activity against human CRMM-1 cells cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay
|
[PMID: 36868105] |
| CRMM-2 | IC50 |
>100 μM
Compound: D1
|
Antiproliferative activity against human CRMM-2 cells cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay
Antiproliferative activity against human CRMM-2 cells cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay
|
[PMID: 36868105] |
| DLD-1 | EC50 |
>100 μM
Compound: 2
|
Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
|
[PMID: 36356534] |
| FHC | CC50 |
>100 μM
Compound: 2
|
Cytotoxicity against human FHC cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
Cytotoxicity against human FHC cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
|
[PMID: 36356534] |
| HCT-116 | EC50 |
>100 μM
Compound: 2
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
|
[PMID: 36356534] |
| HCT-116 | EC50 |
>100 μM
Compound: 2
|
Cytotoxicity against p53-/- human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
Cytotoxicity against p53-/- human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
|
[PMID: 36356534] |
| HEK-293T | IC50 |
38 μg/mL
Compound: Beta-phenylpropiophenone
|
Antagonist activity at HA-tagged mouse AT1a angiotensin 2 receptor expressed in HEK293T cells assessed as decrease in angiotensin 2-induced intracellular calcium uptake
Antagonist activity at HA-tagged mouse AT1a angiotensin 2 receptor expressed in HEK293T cells assessed as decrease in angiotensin 2-induced intracellular calcium uptake
|
[PMID: 18672373] |
| HT-29 | EC50 |
>100 μM
Compound: 2
|
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
|
[PMID: 36356534] |
Chemical Information
-
CAS No. 1083-30-3
-
Appearance Solid
-
Masse moléculaire 210.27
-
Formule C15H14O
-
Color White to off-white
-
SMILES
O=C(CCC1=CC=CC=C1)C2=CC=CC=C2
-
Synonyms
3-Phenylpropiophenone; β-Phenylpropiophenone
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Store at room temperature 3 years
In solvent -80°C 2 years -20°C 1 year
Solvant et solubilité
DMSO : 50 mg/mL (237.79 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (11.89 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureté et documentation
-
Fiche technique (270 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.7558 mL | 23.7790 mL | 47.5579 mL | 118.8948 mL |
| 5 mM | 0.9512 mL | 4.7558 mL | 9.5116 mL | 23.7790 mL | |
| 10 mM | 0.4756 mL | 2.3779 mL | 4.7558 mL | 11.8895 mL | |
| 15 mM | 0.3171 mL | 1.5853 mL | 3.1705 mL | 7.9263 mL | |
| 20 mM | 0.2378 mL | 1.1889 mL | 2.3779 mL | 5.9447 mL | |
| 25 mM | 0.1902 mL | 0.9512 mL | 1.9023 mL | 4.7558 mL | |
| 30 mM | 0.1585 mL | 0.7926 mL | 1.5853 mL | 3.9632 mL | |
| 40 mM | 0.1189 mL | 0.5945 mL | 1.1889 mL | 2.9724 mL | |
| 50 mM | 0.0951 mL | 0.4756 mL | 0.9512 mL | 2.3779 mL | |
| 60 mM | 0.0793 mL | 0.3963 mL | 0.7926 mL | 1.9816 mL | |
| 80 mM | 0.0594 mL | 0.2972 mL | 0.5945 mL | 1.4862 mL | |
| 100 mM | 0.0476 mL | 0.2378 mL | 0.4756 mL | 1.1889 mL |
Dihydrochalcone Related Classifications
HY-114508 Related Classifications
Powered by Bioz